Ghrelin protects spinal cord motoneurons against chronic glutamate-induced excitotoxicity via ERK1/2 and phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β pathways
- PMID: 21530509
- DOI: 10.1016/j.expneurol.2011.04.003
Ghrelin protects spinal cord motoneurons against chronic glutamate-induced excitotoxicity via ERK1/2 and phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β pathways
Abstract
Excitotoxic degeneration of spinal cord motoneurons has been proposed as a pathogenic mechanism in amyotrophic lateral sclerosis (ALS). Recently, we have reported that ghrelin, an endogenous ligand for growth hormone secretagogue receptor (GHS-R) 1a, functions as a neuroprotective factor in various animal models of neurodegenerative diseases. In this study, the potential neuroprotective effects of ghrelin against chronic glutamate-induced cell death were studied by exposing organotypic spinal cord cultures (OSCC) to threohydroxyaspartate (THA), as a model of excitotoxic motoneuron degeneration. Ghrelin receptor was expressed on spinal cord motoneurons. Exposure of OSCC to THA for 3 weeks resulted in a significant loss of motoneurons. However, THA-induced loss of motoneurons was significantly reduced by treatment of ghrelin. Exposure of OSCC to the receptor-specific antagonist D-Lys-3-GHRP-6 abolished the protective effect of ghrelin against THA. Treatment of spinal cord cultures with ghrelin caused rapid phosphorylation of extracellular signal-regulated kinase 1/2, Akt, and glycogen synthase kinase-3β (GSK-3β). The effect of ghrelin on motoneuron survival was blocked by the MEK inhibitor PD98059 and the phosphatidylinositol-3-kinase (PI3K) inhibitor LY294002. Taken together, these findings indicate that ghrelin has neuroprotective effects against chronic glutamate toxicity by activating the MAPK and PI3K/Akt signaling pathways and suggest that administration of ghrelin may have the potential therapeutic value for the prevention of motoneuron degeneration in human ALS. Our data also suggest that PI3K/Akt-mediated inactivation of GSK-3β in motoneurons contributes to the protective effect of ghrelin.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.J Neurochem. 2008 May;105(4):1080-90. doi: 10.1111/j.1471-4159.2007.05206.x. Epub 2007 Dec 25. J Neurochem. 2008. PMID: 18182045
-
Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells.J Endocrinol. 2008 Sep;198(3):511-21. doi: 10.1677/JOE-08-0160. Epub 2008 Jun 9. J Endocrinol. 2008. PMID: 18541646
-
Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition.Neuroscience. 2009 Feb 18;158(4):1348-55. doi: 10.1016/j.neuroscience.2008.10.060. Epub 2008 Nov 8. Neuroscience. 2009. PMID: 19041930
-
Emerging targets in amyotrophic lateral sclerosis (ALS): The promise of ATP-binding cassette (ABC) transporter modulation.Behav Brain Res. 2025 Jan 5;476:115242. doi: 10.1016/j.bbr.2024.115242. Epub 2024 Sep 5. Behav Brain Res. 2025. PMID: 39243983 Review.
-
The neurotrophic and neuroprotective effects of psychotropic agents.Dialogues Clin Neurosci. 2009;11(3):333-48. doi: 10.31887/DCNS.2009.11.3/jhunsberger. Dialogues Clin Neurosci. 2009. PMID: 19877500 Free PMC article. Review.
Cited by
-
ERK1/2 in immune signalling.Biochem Soc Trans. 2022 Oct 31;50(5):1341-1352. doi: 10.1042/BST20220271. Biochem Soc Trans. 2022. PMID: 36281999 Free PMC article. Review.
-
The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis.Mol Psychiatry. 2015 Apr;20(4):500-8. doi: 10.1038/mp.2014.34. Epub 2014 Apr 22. Mol Psychiatry. 2015. PMID: 24751964 Free PMC article.
-
The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective.J Diabetes Res. 2017;2017:4527980. doi: 10.1155/2017/4527980. Epub 2017 Sep 7. J Diabetes Res. 2017. PMID: 29082258 Free PMC article. Review.
-
Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions.Degener Neurol Neuromuscul Dis. 2017 Jul 25;7:95-108. doi: 10.2147/DNND.S120607. eCollection 2017. Degener Neurol Neuromuscul Dis. 2017. PMID: 30050381 Free PMC article. Review.
-
MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.Int J Mol Sci. 2018 Jun 18;19(6):1800. doi: 10.3390/ijms19061800. Int J Mol Sci. 2018. PMID: 29912176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous